CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-24.79%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.67B
AUM Growth
+$1.67B
(-13%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
63.16%
Holding
36
New
8
Increased
12
Reduced
6
Closed
7
Top Buys
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$130M |
| 2 |
GSK
GSK
|
$114M |
| 3 |
AbbVie
ABBV
|
$91.4M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$69.6M |
| 5 |
Ventas
VTR
|
$67M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$191M |
| 2 |
Gilead Sciences
GILD
|
$97.5M |
| 3 |
DaVita
DVA
|
$75M |
| 4 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$69.9M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$58M |
Sector Composition
| 1 | Healthcare | 85.42% |
| 2 | Technology | 7.76% |
| 3 | Real Estate | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $148M | 8.85% | 1,650,000 +775,000 | +89% | +$69.6M |
|
|
CHNG
2
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $130M | 7.76% | +13,000,000 | New | +$130M |
|
3
Viatris
VTRS
$12.3B
| $116M | 6.94% | 7,795,000 -955,000 | -11% | -$14.2M |
|
|
4
GSK
GSK
$79.9B
| $114M | 6.79% | +3,000,000 | New | +$114M |
|
5
Universal Health Services
UHS
$11.6B
| $111M | 6.66% | 1,125,000 +625,000 | +125% | +$61.9M |
|
6
Perrigo
PRGO
$3.27B
| $96.2M | 5.74% | 2,000,000 +300,000 | +18% | +$14.4M |
|
|
7
AbbVie
ABBV
$372B
| $91.4M | 5.46% | +1,200,000 | New | +$91.4M |
|
8
Alkermes
ALKS
$4.78B
| $87.2M | 5.21% | 6,050,000 +1,925,000 | +47% | +$27.8M |
|
|
9
Ventas
VTR
$30.9B
| $87.1M | 5.2% | 3,250,000 +2,500,000 | +333% | +$67M |
|
10
HCA Healthcare
HCA
$94.5B
| $76.4M | 4.56% | 850,000 +450,000 | +113% | +$40.4M |
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $70.9M | 4.23% | 725,000 +125,000 | +21% | +$12.2M |
|
12
Biogen
BIIB
$19.4B
| $63.3M | 3.78% | 200,000 -150,000 | -43% | -$47.5M |
|
13
Ascendis Pharma
ASND
$11.8B
| $60.4M | 3.61% | 536,710 -126,290 | -19% | -$14.2M |
|
|
MNTA
14
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $54.4M | 3.25% | 2,000,000 -1,250,000 | -38% | -$34M |
|
15
Nektar Therapeutics
NKTR
$568M
| $53.6M | 3.2% | 3,000,000 -750,000 | -20% | -$13.4M |
|
16
Brookdale Senior Living
BKD
$1.83B
| $53M | 3.17% | 17,000,000 +4,500,000 | +36% | +$14M |
|
17
Tenet Healthcare
THC
$16.3B
| $50.4M | 3.01% | 3,500,000 +1,000,000 | +40% | +$14.4M |
|
18
Myriad Genetics
MYGN
$593M
| $33.6M | 2.01% | 2,350,000 +1,350,000 | +135% | +$19.3M |
|
19
Collegium Pharmaceutical
COLL
$1.22B
| $32.7M | 1.95% | +2,000,000 | New | +$32.7M |
|
|
AMAG
20
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $27.1M | 1.62% | 4,390,000 | – | – |
|
21
Incyte
INCY
$16.5B
| $26.4M | 1.58% | +360,457 | New | +$26.4M |
|
|
TECX
22
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $21M | 1.25% | 1,350,000 +750,000 | +125% | +$11.7M |
|
|
TBIO
23
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $17.6M | 1.05% | 1,765,000 +265,000 | +18% | +$2.64M |
|
24
Puma Biotechnology
PBYI
$254M
| $16.5M | 0.98% | +1,950,000 | New | +$16.5M |
|
25
Atara Biotherapeutics
ATRA
$84.6M
| $12.6M | 0.75% | 1,478,753 -1,471,247 | -50% | -$12.5M |
|